Merve Nur Atas

2PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 16, 2022
The inhibitory effect of betulinic acid on epithelial-mesenchymal transition pathway in renal cell carcinoma.

Merve Nur Ataş, Barış Ertuğrul, Elif Sinem İplik

|Jun 25, 2021
Levofloxacin might be safe to use for OSCC patients.

Levent Aydemir, Elif Sinem Iplik, Baris Ertugrul

Pageof 1

Frequent Collaborators

2 joint publications

Elif Sinem Iplik

2 joint publications

Arzu Ergen

2 joint publications

Bedia Cakmakoglu

1 joint publications

Levent Aydemir